Saturday 17 October 2026 Export VEEV’s income statement to Excel — free account

Veeva Systems Inc.

VEEV Healthcare Health Information Services

Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.

310.30 2.73 −0.87%

Follow VEEV

Alert me

Market cap: $50.7B
P/E: 50.0×
Fwd P/E: 26.9×
Dividend yield: —
F-score: 7/9
Altman Z: 13.57
Beneish M: −2.63
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insider Decisions trades per month

Total sells 15.28

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	1	—	1	2	—	—	1	2	2	1

Insider Ownership 9.08%

Capital & Financial Ratios $m

Market Cap 50,680.00

Revenue 3,458.10

Net Income 1,014.77

Free Cash Flow 1,638.77

Net Debt (7,242.95)

Current Ratio 5.46

Debt/Equity 0.00

P/E ratio 49.97

Fwd P/E 26.90

P/S ratio 14.57

P/B ratio 6.78

Past 5Y EPS Growth 18.18%

This Y EPS Growth 14.03%

Next Y EPS Growth 11.19%

Next Y revenue growth 15.48%

Next 5Y EPS Growth 12.51%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 10.54%

10-year low 10-year high

P/S against its own 10 years 50.50%

10-year low 10-year high

P/B against its own 10 years 20.94%

10-year low 10-year high

EV/Sales against its own 10 years 46.22%

10-year low 10-year high

EV/FCF against its own 10 years 11.54%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2027	Powerpack
2026	Powerpack
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2018	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2024	2025	2026	Q'26
Cash	4,028	5,150	6,561	7,243
Receivables	889	1,057	1,310	566
Inventory	—	—	—	—
Other	87	101	—	—
	5,003	6,309	7,998	7,946

	2024	2025	2026	Q'26
Payables	32	30	38	36
ST’ Debt	—	—	—	—
Other	—	—	—	—
	1,179	1,398	1,637	1,456

Compound Annual Growth %

	10y	5y	3y
Sales	22.82%	16.88%	14.03%
Cash Flow	33.26%	20.75%	21.94%
Earnings	32.52%	19.05%	23.06%
Book Value	30.46%	26.06%	24.75%

Revenue $m

	Apr	Jul	Oct	Jan	Year
’26	883	928	—	—	—
’26	759	789	811	836	3,195
’25	650	676	699	721	2,747
’24	526	590	617	631	2,364
’23	505	534	552	563	2,155
’22	434	456	476	485	1,851
’21	337	354	378	397	1,465

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Apr	Jul	Oct	Jan	Year
’26	1,127	239	—	—	—
’26	877	238	193	107	1,415
’25	764	93	164	70	1,090
’24	506	265	83	58	911
’23	481	93	143	63	780
’22	478	119	113	54	764
’21	282	105	95	68	551

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Apr	Jul	Oct	Jan	Year
’26	1,125	231	—	—	—
’26	871	232	183	100	1,386
’25	755	90	160	65	1,070
’24	503	255	77	50	885
’23	479	92	137	59	767
’22	476	114	111	50	750
’21	282	100	92	68	543

Fiscal quarters ending in the months shown.

EPS $

	Apr	Jul	Oct	Jan	Year
’26	1.57	1.66	—	—	—
’26	1.37	1.19	1.40	1.45	5.44
’25	0.98	1.04	1.13	1.18	4.32
’24	0.81	0.68	0.83	0.90	3.22
’23	0.62	0.56	0.67	1.16	3.00
’22	0.71	0.67	0.65	0.60	2.63
’21	0.54	0.58	0.60	0.64	2.36

Fiscal quarters ending in the months shown.

Group	Line	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026	2027e
Price, $
Price, $	Low	40.71	52.17	82.41	118.11	235.74	151.02	157.00	170.25	201.54	148.05	Analyst estimates 2027–2029 Powerpack
	High	68.07	109.05	176.90	313.99	343.96	257.68	225.49	258.93	310.50	319.95
People
People	Employees	1,794	2,171	2,553	3,501	4,506	5,482	6,744	7,172	7,291	7,928
	Revenue/emp, $m	0.31	0.32	0.34	0.32	0.33	0.34	0.32	0.33	0.38	0.40
Income, $m
Income, $m	Revenue	551	691	862	1,104	1,465	1,851	2,155	2,364	2,747	3,195
	Gross margin, %	68.45	69.38	71.55	72.52	72.09	72.79	71.72	71.35	74.53	75.53
	EBT	122	166	239	314	394	512	509	588	919	1,195
	EBT margin, %	22.22	24.01	27.68	28.41	26.89	27.68	23.62	24.88	33.47	37.38
	Net income	78	151	230	301	380	427	488	526	714	909
	Depreciation	30	32	30	37	53	60	48	24	30	45
Per share, $
Per share, $	Revenue	4.06	4.92	5.98	7.47	9.72	12.08	13.87	14.72	16.97	19.52
	Earnings	0.51	1.01	1.59	2.03	2.52	2.79	3.14	3.27	4.41	5.55
	Cash flow	1.06	1.66	2.15	2.96	3.66	4.99	5.02	5.68	6.73	8.65
	Capex	(0.06)	(0.08)	(0.07)	(0.03)	(0.06)	(0.09)	(0.09)	(0.16)	(0.13)	(0.18)
	Free cash flow	1.01	1.58	2.09	2.93	3.60	4.90	4.94	5.51	6.61	8.47
	Book value	4.81	6.46	8.58	11.27	15.04	19.00	23.92	28.93	36.03	44.08
	Shares, m	136	140	144	148	151	153	155	161	162	164
Valuation, ×
Valuation, ×	P/E	73.89	62.24	68.59	71.87	112.27	84.78	54.49	63.23	52.89	36.57
	P/S	10.43	12.77	18.25	19.63	29.09	19.59	12.30	14.09	13.75	10.42
	P/B	8.80	9.73	12.71	13.01	18.81	12.45	7.13	7.17	6.47	4.61
	EV/Sales	9.49	11.67	16.98	18.64	27.96	18.30	10.86	12.38	11.87	8.36
	EV/FCF	38.28	36.29	48.64	47.53	75.50	45.15	30.51	33.07	30.49	19.28
Cash, $m
Cash, $m	Operating cash flow	144	233	311	437	551	764	780	911	1,090	1,415
	Capex	(8)	(11)	(10)	(4)	(9)	(14)	(14)	(26)	(21)	(29)
	Free cash flow	137	222	301	433	543	750	767	885	1,070	1,386
Balance, $m
Balance, $m	Working capital	465	706	1,032	980	1,595	2,266	2,963	3,824	4,910	6,361
	Total debt	—	—	—	55	63	55	61	—	—	—
	Net debt	(519)	(762)	(1,090)	(1,087)	(1,664)	(2,376)	(3,103)	(4,028)	(5,150)	(6,561)
	Shareholders’ equity	653	906	1,238	1,666	2,266	2,912	3,716	4,645	5,832	7,215
Returns, %
Returns, %	ROA	9.56	14.08	15.94	15.34	14.29	12.46	11.31	9.81	10.78	11.14
	ROIC	56.38	68.41	94.38	30.90	39.18	58.99	46.76	43.49	63.35	87.58
	ROE	13.40	19.40	21.44	20.74	19.33	16.51	14.72	12.58	13.63	13.93

Negative figures in brackets.

All 10 years →

Fiscal years to Jan 2026 · latest quarter Jul 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
VEEV Veeva Systems Inc.	$50.7B	50.0×	26.9×	+17.60% (above 0%: growing)	+36.59% (above 0%: growing)	−0.62% (below 0%: shrinking)	75.00%	29.64%
TEM Tempus AI, Inc.	$12.8B	— (loss-making)	— (loss-making)	+21.56% (above 0%: growing)	n/m	−153.72% (below 0%: shrinking)	64.45%	(19.85%)	Compare
BTSG BrightSpring Health Services, Inc.	$12.3B	34.0×	37.6×	+23.05% (above 0%: growing)	+192.86% (above 0%: growing)	−39.62% (below 0%: shrinking)	12.72%	3.37%	Compare
TXG 10x Genomics	$9.4B	— (loss-making)	— (loss-making)	−12.65% (below 0%: shrinking)	n/m	−4.61% (below 0%: shrinking)	74.48%	(12.95%)	Compare
HNGE Hinge Health Inc.	$8.5B	73.5×	39.4×	+53.00% (above 0%: growing)	n/m	+441.14% (above 0%: growing)	86.44%	19.00%	Compare
HQY HealthEquity, Inc.	$7.7B	33.0×	30.2×	+7.64% (above 0%: growing)	+14.49% (above 0%: growing)	−3.44% (below 0%: shrinking)	73.55%	28.14%	Compare
DOCS Doximity, Inc.	$5.6B	34.8×	26.2×	+7.34% (above 0%: growing)	−53.57% (below 0%: shrinking)	−34.14% (below 0%: shrinking)	84.87%	21.48%	Compare
WAY Waystar Holding Corp.	$5.4B	38.0×	22.4×	+18.11% (above 0%: growing)	+10.53% (above 0%: growing)	−52.42% (below 0%: shrinking)	69.44%	23.79%	Compare
HTFL Heartflow, Inc.	$4.4B	— (loss-making)	— (loss-making)	+47.57% (above 0%: growing)	n/m	+62.62% (above 0%: growing)	83.00%	(27.93%)	Compare
Median of peers	$8.1B	34.8×	30.2×	+19.84%	+12.51%	−19.37%	74.02%	11.19%

All 51 Health Information Services stocks →

Veeva Systems Inc. (VEEV) key facts

Strength: Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025.
Veeva Systems Inc. (VEEV) is a Health Information Services company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 16, 2026, VEEV traded at $310.30, a market capitalization of $50.7 billion.
Return on equity was 13.9% and debt-to-equity 0.00.
Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 13.57 (safe zone) for fiscal 2026.

Source: company filings (standardised) and stockrow calculations.